TABLE 3.
The chi-square test of the relation between risk score and clinical features in ICGC cohort.
Clinical feature | Risk score |
c2 | p | |
High risk n(%) | Low risk n(%) | |||
Age | 0.856 | 0.355 | ||
>65 | 49(35.25%) | 90(64.75%) | ||
≤65 | 36(41.38%) | 51(58.62%) | ||
Gender | 0.023 | 0.881 | ||
MALE | 53(34.42%) | 101(65.58%) | ||
FEMALE | 20(33.33%) | 40(66.67%) | ||
Prior malignancy | 0.201 | 0.654 | ||
Yes | 12(41.38%) | 17(58.62%) | ||
No | 73(37.06%) | 124(62.95%) | ||
Stage | 10.132 | 0.001 | ||
I–II | 41(29.50%) | 98(70.50%) | ||
III–IV | 44(50.57%) | 43(49.43%) |